Hosted on MSN2mon
23andMe has been quietly exploring a possible sale of its telehealth business, Lemonaid23andMe has been testing the waters for a buyer for Lemonaid Health, the virtual-care business it bought in 2021 for $400 million in cash and stock, people with knowledge of the efforts told BI.
Consumer DNA testing company 23andMe has signed a deal to acquire privately-held Lemonaid Health in a $400 million ... with the remainder in the form of stock. The transaction is expected to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results